Mission Bio raises $30M in Series B round to develop genomics platform
The company said it would use the funding to expand its single-cell DNA sequencing platform into CRISPR applications and global markets.
The company said it would use the funding to expand its single-cell DNA sequencing platform into CRISPR applications and global markets.
Agilent Technologies will expand research on cell metabolism to better understand things like neurodegeneration, aging, cancer, cardiovascular disease and cell physiology with its acquisition of Seahorse Bioscience.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.